1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Equipment & Services
Hi-Clearance Inc.

Hi-Clearance Inc.

1788.TWO
Hi-Clearance Inc.TW flagTaipei Exchange
134.00
TWD
-0.50
- -
5.97BMarket Cap
Hi-Clearance Inc.
1788.TWO
(Taipei Exchange)

Recent

price

134.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
68.17
70
67.06
74.62
75.8
77.15
79.76
83.32
87.54
90.21
93.39
94.04
116
89.62
91.48
- -
96
Revenue per Share
4.7
4.66
5.26
6.17
6.19
6.11
5.84
7.07
6.89
6.84
8.63
8.9
9.06
8.01
8.08
- -
8.27
Basic EPS, GAAP
4.24
4.04
-8.41
9.92
0.05
1.09
8.98
3.71
1.29
6.08
4.93
3.5
7.43
8.49
5.07
- -
6.25
Free Cash Flow per Basic Share
3.15
3.37
3.45
3.94
4.93
4.93
4.93
4.93
5.94
6.01
5.88
6.72
7.02
7.17
7
- -
- -
Dividend per Share
15.69
21.92
20.04
22.33
23.5
24.35
25.23
27.35
27.87
28.46
30.51
31.1
32.49
31.96
32.29
- -
33.54
Book Value per Share
28.43
42.85
38.23
40.5
41.68
41.76
42.66
44.55
45.2
48.36
49.18
53.9
55.92
64.3
63.51
- -
63.44
Tangible Book Value per Share
30
30
36
36
36
36
36
36
35
36
37
39
40
43
45
- -
45
Basic Weighted Avg Shares
2,023
2,129
2,381
2,650
2,692
2,740
2,833
2,959
3,095
3,241
3,432
3,684
4,690
3,896
4,073
4,278
4,278
Sales/Revenue/Turnover
6.45
6.94
6.2
8.87
9.22
8.49
8.56
9.19
9.59
9.33
10.72
11.23
9.85
10.66
10.51
9.85
9.85
Operating Margin (%)
35
39
35
32
36
37
33
33
38
106
132
151
161
165
179
199
199
Depreciation Expense
140
142
187
219
220
217
208
251
243
246
317
349
366
348
360
369
369
Net Income, GAAP
17.94
18.87
16.66
19.95
19.27
18.12
20.01
16.81
21
20.48
19.02
19.06
18.95
19.88
20.96
19.18
19.18
Effective Tax Rate (%)
6.9
6.66
7.84
8.27
8.16
7.92
7.33
8.49
7.87
7.58
9.25
9.46
7.81
8.93
8.83
8.61
8.61
Profit Margin (%)
364
800
851
891
914
979
1,033
1,002
779
1,238
900
824
909
1,387
1,082
1,117
1,117
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
908
823
518
473
482
519
459
459
LT Debt
910
1,368
1,401
1,481
1,523
1,526
1,558
1,625
1,641
1,784
2,013
2,304
2,440
2,984
3,002
3,051
3,051
Total Equity
10.2
9.14
8.09
11.89
11.82
10.88
10.97
12.4
11.8
9.63
9.6
9.84
10.66
9.24
8.79
8.33
8.33
Return on Invested Capital (%)
22.95
19.26
22.01
24.32
22.37
20.69
19.33
22.04
18.88
14.75
14.8
15.2
15.98
16.28
16.65
15.43
15.43
Return on Capital (%)
31.12
25.04
27.08
29.12
26.99
25.53
23.58
26.89
24.88
24.48
29.6
29.8
28.95
25.75
25.45
25.14
25.14
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
495
650
599
LT Borrowings
- -
- -
- -
LT Finance Leases
500
477
459
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
45
45
45
Market Capitalization
6,193
6,195
6,083

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
2,566
2,555
2,658
Cash, Cash Equivalents & STI
609
534
599
Accounts Receivable, Net
1,041
1,072
1,028
Inventories
644
671
745
Total Current Liabilities
1,629
1,504
1,541
Payables & Accruals
- -
- -
- -
ST Debt
495
650
599
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.38%
8.98%
1.63%
Free Cash Flow
106.63%
20.43%
23.45%
Net Income, GAAP
5.94%
3.15%
2.45%
Sales/Revenue/Turnover
5.03%
5.46%
5.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
973
956
984
982
3,896
2024
965
1,097
1,009
1,002
4,073
2025
1,050
1,070
1,066
1,092
4,278

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
2.11
2.08
1.97
- -
8.01
2024
2.16
2.45
1.85
- -
8.08
2025
1.9
2.2
2.13
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
7.17
2024
- -
- -
- -
- -
7
2025
- -
- -
- -
- -
- -
Similar Companies
Imaging Diagnostic Systems, Inc. (IMDS)
DENTSPLY SIRONA Inc. (DY2.DE)
Bactiguard Holding AB (publ) (0QV2.L)
Balaxi Pharmaceuticals Limited (BALAXI.NS)
Bastide Le Confort Médical S.A. (0IP1.L)
Hologic, Inc. (0J5Q.L)
Business
Hi-Clearance Inc. Hi-Clearance Inc. is a Taiwan-based company principally engaged in the distribution and sales of medical equipment, biochemical reagents and devices across renal, cardiac, radiation, dental, oral surgery and metabolism markets. The company offers dialyzers, dialysis and reverse osmosis machines, related consumables and drugs including blood tubings, puncture needles, physiological saline, sanitizing liquids, dialysis liquids and powders, and erythropoietin; interventional cardiology and radiology devices, vascular surgery products, and Inoue balloon catheters; dental consumables, implant materials and equipment; blood glucose monitors, related consumables and nutrition products; artificial dermises; and hemodialysis management services, as well as design and operation of dialysis centers. Hi-Clearance Inc. also sells and services healthy natural drinks and acts as an OEM supplier for beverage raw materials and concentrates. Founded in 1989 and headquartered in New Taipei City at 8F-2, No. 2, Lane 609, Sec. 5, Chongxin Rd., Sanchong Dist., the company primarily serves the Taiwan healthcare market with additional branches including Taichung, Tainan and Kaohsiung service centers.